Mayr Melnhof Karton【MYM】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
ドイツ
TG
Mayr Melnhof Karton AG (MYM) 銘柄情報

Mayr Melnhof Karton AG (MYM)

72.00

-1.20

(-1.64%)

終了 11月27日 6:00AM

リアルタイムデータ

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

72.00

買値

71.60

売値

72.30

出来高

231

71.60 日の範囲 73.40

70.30 52 週間の範囲 129.00

時価総額

前日終値

73.20

始値

73.40

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

616

発行済株式数

20,000,000

配当利回り

2.08%

PER

16.79

1 株当たり利益 (EPS)

4.36

歳入

4.24B

純利益

87.2M

セクター

Paperboard Mills

業界

Paper & Paper Prods Div

ウェブサイト

www.mayr-melnhof.com

本社

Vienna, Aut

設立

1990

Mayr Melnhof Karton AG is listed in the Paperboard Mills sector of the Tradegate (DE) with ticker MYM. The last closing price for Mayr Melnhof Karton was 73.20 €. Over the last year, Mayr Melnhof Karton shares have traded in a share price range of 70.30 € to 129.00 €.

Mayr Melnhof Karton currently has 20,000,000 shares in issue. The market capitalisation of Mayr Melnhof Karton is 1.46 € billion. Mayr Melnhof Karton has a price to earnings ratio (PE ratio) of 16.79.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.3	-0.414937759336	72.3	73.7	70.3	418	72.03845008	DE
4	-10.599999	-12.8329287268	82.599999	83.4	70.3	633	76.41560142	DE
12	-24.8	-25.6198347107	96.8	96.8	70.3	616	84.08432465	DE
26	-43.8	-37.8238341969	115.8	117.6	70.3	413	91.07519812	DE
52	-39.8	-35.5992844365	111.8	129	70.3	358	101.67743415	DE
156	-98	-57.6470588235	170	193.6	70.3	179	114.21581706	DE
260	-105.8	-59.5050618673	177.8	193.6	70.3	178	114.35772976	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
2RZPoseida Therapeutics Inc	8.90 € (225.77%)	48.28k
GMEGeratherm Medic	5.55 € (83.77%)	91.55k
7S2Scotch Creek Ventures Inc	0.0144 € (67.44%)	100k
ZN80Hesai Group	7.20 € (59.29%)	37.64k
AXIAtos SE	0.595 € (57.62%)	3.04M
CHPCitigold Corporation Ltd	0.001 € (-60.00%)	250k
L7C2Windfall Geotek Inc	0.0025 € (-54.55%)	500
QN90Military Metals Corp	0.278 € (-36.53%)	324.13k
PKTMPIERER Mobility AG	9.06 € (-35.74%)	173.35k
0Z2Alector Inc	2.44 € (-35.45%)	34.44k
R1EAEV Resources Ltd	0.002 € (25.00%)	4.8M
D7GNel ASA	0.272 € (1.12%)	3.14M
AXIAtos SE	0.595 € (57.62%)	3.04M
PF8European Lithium Limited	0.0168 € (0.00%)	2.96M
3CPXiaomi Corporation	3.2835 € (-5.40%)	2.09M

amrwonderful

amrwonderful 2分前

Shares short-3.21 Miilion-11/15/24

Mactheriverrat

Mactheriverrat 2分前

SGMO - Nice day and the start of another uptrend

north40000

north40000 2分前

How about a M/A draft agreement, not completed, where the approved drug is consequential to the buyout price, forms part of consideration or $$$value of agreement, or even the existence of an agreement? The FDA-approved drug could be in process of being auctioned to a select group of would-be buyers

dinogreeves

dinogreeves 4分前

I have learned over the years not all traders know everything about trading, in-fact 97% of them don't know jack chit. Today was a proven fact with this latest filings, that no one can read filings or cares to even read filings, they are in for quick buck or two for ends meet. About couple of week

CrossFireTrader

CrossFireTrader 4分前

To avoid the wash you have to wait until after 31 days to buy it back is that correct ?

Hanibal

Hanibal 7分前

I know nothing about anything

Yeah we know. You've made that clear. That's why you're still here over a year later, hoping that a dead and deleted stock will come back to life and return you the money you lost.

It's just too gosh darn bad that it's fictitious nonsense.

CrossFireTrader

CrossFireTrader 9分前

Before 31 days of after 31 days

EternalPatience

EternalPatience 10分前

The watermark says capitalforum.con for what's worth to anyone

gfp927z

gfp927z 14分前

Xena, I wasn't implying that Cipro would have been the cause of your B-12 deficiency (if you have one). B-12 deficiencies are actually very common (see Gundry video below) -

https://www.youtube.com/watch?v=opmvTl8hvYY

---

StayHumble

StayHumble 15分前

100% Xpert BUYS💹 wow interest is growing💹💹 https://ih.advfn.com/stock-market/USOTC/digital-brand-media-and-pk-DBMM/trades

GoliathRulz

GoliathRulz 16分前

I see that upward trend is still continuing. Lol. $GMER … the $hit stock that never disappoints.

lakers17

lakers17 17分前

Judge isn't hanging around Thanksgiving week. I expect the hammer to come down on NSAV early next week. Notice no late filing filed? NSAV is in huge trouble. I am pretty much always right on NSAV. The pumper clowns have been wrong just about 100% from.021 to trips.

Golden Cross

Golden Cross 17分前

$CHSN Chanson and Xinjiang Hengtai Investment expand Soul ? Song in Yili, China
https://finance.yahoo.com/news/chanson-xinjiang-hengtai-investment-expand-102145163.html

StayHumble

StayHumble 17分前

Xcellent! "Funders Wait✅2Ensure $DBMM Still Trades"✅

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its registration.

CONCLUSION

IceCold8

IceCold8 18分前

Someone had to!

3331

BIEL: HUGE NEWS - Flagship product RecoveryRX is now available at every Veterans Administration clinic and hospital nationwide!

https://kellycovemobility.com/rrx/
An American hero gives a fantastic testimonial about Bioelectronics flagship product - RecoveryRX!
https://i

3331

BIEL: HUGE NEWS - Flagship product RecoveryRX is now available at every Veterans Administration clinic and hospital nationwide!

https://kellycovemobility.com/rrx/
An American hero gives a fantastic testimonial about Bioelectronics flagship product - RecoveryRX!
https://i

FFFacts

FFFacts 21分前

Degenerates. I have some information to share by end of next week.

Golden Cross

Golden Cross 22分前

$WONDF WonderFi Surpasses $2 Billion in Client Assets Under Custody

Toronto, Ontario--(Newsfile Corp. - November 26, 2024) - WonderFi Technologies Inc. (TSX: $WNDR ) (OTCQB: WONDF) ("WonderFi" or the "Company"), a global leader in centralized and decentralized financial services and p

Mayr Melnhof Karton

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約